The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo

被引:107
作者
Duncan, GS
Mittrucker, HW
Kagi, D
Matsuyama, T
Mak, TW
机构
[1] AMGEN INST, TORONTO, ON M5G 2M9, CANADA
[2] UNIV TORONTO, ONTARIO CANC INST, DEPT IMMUNOL, TORONTO, ON M4X 1K9, CANADA
[3] UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON M4X 1K9, CANADA
关键词
D O I
10.1084/jem.184.5.2043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The activation of natural killer (NK) cells, cytotoxic lymphocytes capable of major histocompatibility complex (MHC)-unrestricted killing and early antiviral defense, is temporally related to the increased interferon (IFN)-alpha/beta production that is seen in the viral infection of mice. Type I IFN (IFN-alpha/beta) are expressed in many cell types early after primary viral infection and have been shown to mediate resistance against a variety of viruses. In this study, the role of the transcriptional activator IFN regulatory factor-1 (IRF-1) in murine NK cell activity was assessed. IRF-1-deficient mice displayed a normal frequency of NK marker-positive cells, but exhibited greatly reduced NK cell-mediated cytotoxicity after both virus infection and stimulation with the IFN inducer polyinosinic:polycytidilic acid in vivo. In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12. IRF-1-deficient mice were unable to eliminate syngeneic MHC class I-negative tumor cells in vivo, and had a reduced ability to reject parental semi-allogeneic donor cells from the circulation. Thus, IRF-1 is essential for the induction of NK cell-mediated cytotoxicity and for the in vivo effector functions that are mediated by this activity.
引用
收藏
页码:2043 / 2048
页数:6
相关论文
共 24 条
[1]   CYTOKINES IN THE GENERATION OF IMMUNE-RESPONSES TO, AND RESOLUTION OF, VIRUS-INFECTION [J].
BIRON, CA .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (04) :530-538
[2]   INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[3]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[4]   INDUCTION OF THE TRANSCRIPTION FACTOR IRF-1 AND INTERFERON-BETA MESSENGER-RNAS BY CYTOKINES AND ACTIVATORS OF 2ND-MESSENGER PATHWAYS [J].
FUJITA, T ;
REIS, LFL ;
WATANABE, N ;
KIMURA, Y ;
TANIGUCHI, T ;
VILCEK, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9936-9940
[5]   ABSENCE OF THE TYPE-I IFN SYSTEM IN EC CELLS - TRANSCRIPTIONAL ACTIVATOR (IRF-1) AND REPRESSOR (IRF-2) GENES ARE DEVELOPMENTALLY REGULATED [J].
HARADA, H ;
WILLISON, K ;
SAKAKIBARA, J ;
MIYAMOTO, M ;
FUJITA, T ;
TANIGUCHI, T .
CELL, 1990, 63 (02) :303-312
[6]   STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES [J].
HARADA, H ;
FUJITA, T ;
MIYAMOTO, M ;
KIMURA, Y ;
MARUYAMA, M ;
FURIA, A ;
MIYATA, T ;
TANIGUCHI, T .
CELL, 1989, 58 (04) :729-739
[7]   INTERLEUKIN-2 AUGMENTS NATURAL-KILLER CELL-ACTIVITY [J].
HENNEY, CS ;
KURIBAYASHI, K ;
KERN, DE ;
GILLIS, S .
NATURE, 1981, 291 (5813) :335-338
[8]   CYTOTOXICITY MEDIATED BY T-CELLS AND NATURAL-KILLER-CELLS IS GREATLY IMPAIRED IN PERFORIN DEFICIENT MICE [J].
KAGI, D ;
LEDERMANN, B ;
BURKI, K ;
SEILER, P ;
ODERMATT, B ;
OLSEN, KJ ;
PODACK, ER ;
ZINKERNAGEL, RM ;
HENGARTNER, H .
NATURE, 1994, 369 (6475) :31-37
[9]   REQUIREMENT FOR TRANSCRIPTION FACTOR IRF-1 IN NO SYNTHASE INDUCTION IN MACROPHAGES [J].
KAMIJO, R ;
HARADA, H ;
MATSUYAMA, T ;
BOSLAND, M ;
GERECITANO, J ;
SHAPIRO, D ;
LE, J ;
KOH, SI ;
KIMURA, T ;
GREEN, SJ ;
MAK, TW ;
TANIGUCHI, T ;
VILCEK, J .
SCIENCE, 1994, 263 (5153) :1612-1615
[10]   SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY [J].
KARRE, K ;
LJUNGGREN, HG ;
PIONTEK, G ;
KIESSLING, R .
NATURE, 1986, 319 (6055) :675-678